Release to Process is an enhancement to biotherapy orders that accommodates releasing product to the lab for reprocessing.
Writing the order—The reprocessing is initiated as a release order with the selection of a Release to Process template. Only templates built with Release to Process in the name, and both the Collection Location and Process Collected set to “ReProcess,” have the linked release and process orders for reprocessing selected product. On completing the release order, the provider is prompted to write the associated process order. Both orders are saved once the process order is signed. In the Zoom detailed view and printout of both orders, the associated order for process or release displays with the BOE order ID.
Associated orders—The release and process orders that are generated are linked together—one cannot be created without the other. If the release order is signed and the process order is then canceled, the release order is also canceled, and the selected product is returned to the patient's inventory. After writing the release order, if the ordering provider times out, backs out, or exits out of writing associated the process order without choosing to cancel, the release order will not be saved. After 15 minutes the selected product is returned to the patient’s inventory. Once the orders are saved, canceling either the release or the process order in BOE will cancel the associated order and return the product to the patient’s inventory.
RN Confirmation—At DFCI, confirmation of the orders by nursing must be completed in sequence. First the release order must be confirmed to lab, then the process order. On trying to confirm the process order before the release order, the RN can only view the process order.
Lab requirements—In the BPAA (Biotherapy Product Availability Application), the lab must complete the release order before the process order can be started. If the lab cancels the release order through BPAA, the only option for the associated process order is to cancel.